ArticleBiomedical optics express2025
MediONN: an integrated photonic chip optical neural network for deep learning-based semantic segmentation in early detection of pancreatic cancer.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic cancer remains one of the deadliest cancers due to the lack of effective early detection tools. While deep neural networks (DNNs) have shown promise in tumor segmentation, electronic accelerators suffer from power inefficiency and latency. To address this, we propose MediONN-a photonic neural network system implemented on an integrated chip, optimized for 3D medical image segmentation. MediONN integrates a 4×4 photonic neural processor within a hierarchical 3D optical computation framework. To improve training convergence, we introduce a segmentation-specific Gaussian weight initialization strategy, along with 3D optical convolutional layers for volumetric feature extraction. Unlike prior photonic systems focused on classification, MediONN is the first to demonstrate optical neural networks (ONNs) directly applied to 3D segmentation. On the NIH pancreas CT dataset, MediONN achieves a Dice similarity coefficient (DSC) of 0.5215 (2D) and 0.5302 (3D), with peak DSCs of 0.5919 (2D) and 0.8788 (3D). Comprehensive evaluation metrics confirm MediONN's segmentation accuracy is comparable to electronic counterparts, while offering significant gains in computational speed and energy efficiency. These results highlight the scalability and biomedical potential of integrated photonic ONNs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.